A Multiprotein Complex Involved In Atrx Syndrome
A Multiprotein Complex Involved In Atrx Syndrome
批准号:
6969367
负责人:
Weidong Wang
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
ATRX综合征是α -地中海贫血、智力迟钝和多种相关发育异常的组合。ATRX的缺陷基因定位在X染色体上并进行了克隆。同一基因的突变还会导致其他几种形式的x连锁智力迟钝综合症。ATRX基因编码一个含有SWI2/ snf2型dna依赖性atp酶结构域的基因产物。因此,我们假设ATRX可能在atp依赖性染色质重塑复合体中起作用,并参与基因表达的调控。我们与dr。道格·希格斯和理查德·吉本斯,他们克隆了ATRX基因,并发现了其功能的重要特征。通过HeLa提取物的免疫沉淀,我们发现ATRX与转录辅助因子Daxx在一个复合物中。以下证据支持ATRX和Daxx是atp依赖性染色质重塑复合体的组成部分:1)Daxx和ATRX可以通过特异性抗体共同免疫分离;2)通过凝胶过滤分析,一定比例的Daxx与ATRX作为1mda的络合物共分馏;3) ATRX综合征患者细胞提取物中Daxx-ATRX复合物水平相应降低;4) ATRX和Daxx在PML核体中有一定比例的共定位,而Daxx在PML核体中已被发现;5) ATRX复合物显示atp依赖的活性,类似于其他染色质重塑复合物,包括三螺旋DNA位移和单核小体破坏模式的改变。但与先前描述的SWI/SNF或NURD复合物不同,ATRX复合物不会随机化单核小体的DNA相位,这表明它可能以不同的方式重塑染色质。综上所述,结果表明ATRX与Daxx作为一种新的染色质重塑复合体共同起作用。ATR-X综合征的缺陷可能是由该复合体控制的基因表达不当造成的。我们已经确定了几个序列特异性转录因子与Daxx共纯化。我们现在正在研究由这些因子调控的基因是否与ATR-X综合征有关。
英文摘要
ATRX syndrome represents a combination of alpha-thalassemia, mental retardation, and multiple associated developmental abnormalities. The gene defective in ATRX has been localized to the X chromosome and cloned. Mutations in the same gene also cause several other forms of syndromal X-linked mental retardation. The ATRX gene encodes a gene product containing a SWI2/SNF2-type DNA-dependent ATPase domain. Thus, it has been hypothesized that ATRX could function in an ATP-dependent chromatin-remodeling complex and participate in regulation of gene expression. We established a collaboration with Drs. Doug Higgs and Richard Gibbons, who had cloned the ATRX gene, and have discovered important features of its function. By immunoprecipitation from HeLa extract, we found that ATRX is in a complex with transcription cofactor Daxx. The following evidence supports that ATRX and Daxx are components of an ATP-dependent chromatin-remodeling complex: 1) Daxx and ATRX can be coimmunoisolated by antibodies specific for each protein; 2) a proportion of Daxx co-fractionates with ATRX as a complex of 1 MDa by gelfiltration analysis; 3) in extract of cells of a patient with ATRX syndrome, the level of the Daxx-ATRX complex is correspondingly reduced; 4) a proportion of ATRX and Daxx colocalize in PML nuclear bodies, where Daxx had previously been found; and 5) ATRX complex displays ATP-dependent activities that resemble those of other chromatin remodeling complexes, including triple helix DNA displacement and alteration of mononucleosome disruption patterns. But unlike the previously described SWI/SNF or NURD complexes, the ATRX complex does not randomize DNA phasing of the mononucleosomes, suggesting that it may remodel chromatin differently. Taken together, the results suggest that ATRX functions in conjunction with Daxx as a novel chromatin-remodeling complex. The defects in ATR-X syndrome may result from inappropriate expression of genes controlled by this complex.We have identified several sequence-specific transcription factors that co-purify with Daxx. We are now studying if the genes regulated by these factors could be involved in ATR-X syndrome.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment
-
批准号:10529960
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2022
-
负责人:Weidong Wang
-
依托单位:
Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment
-
批准号:10665748
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2022
-
负责人:Weidong Wang
-
依托单位:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
-
批准号:10580851
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2021
-
负责人:Weidong Wang
-
依托单位:
Cytoprotection and the mechanism of action of a natural product Khellin against ER stress
-
批准号:9974514
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2018
-
负责人:Weidong Wang
-
依托单位:
Cytoprotection and the mechanism of action of a natural product Khellin against ER stress
-
批准号:10285537
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2018
-
负责人:Weidong Wang
-
依托单位:
Preclinical Development of Khellin Analogs for Anti-Diabetic Therapy
-
批准号:9336063
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2016
-
负责人:Weidong Wang
-
依托单位:
Preclinical Development of Khellin Analogs for Anti-Diabetic Therapy
-
批准号:9353780
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2016
-
负责人:Weidong Wang
-
依托单位:
Identification and Characterization of human Rsc Chromatin-Remodeling Complex
-
批准号:6431445
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification/characterization Complex-Bloom Syndrome
-
批准号:7132305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Characterization Complex Involved In Rothmund-Thomson
-
批准号:7132306
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification Of A Complex Involved In Bloom Syndrome
-
批准号:6668115
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification And Characterization Of Human Rsc Chromat
-
批准号:6668110
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease
-
批准号:10469229
-
项目类别:
-
资助金额:$21.36万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Structural And Functional Studies Of Human Swi/snf Chromatin-remodeling
-
批准号:10467892
-
项目类别:
-
资助金额:$127.74万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Derivation of pancreatic beta cells from human induced pluripotent stem cells
-
批准号:8466516
-
项目类别:
-
资助金额:$34.44万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigation of an RNA topoisomerase complex involved in Fragile X syndrome
-
批准号:8931567
-
项目类别:
-
资助金额:$64.26万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Characterization of a Complex Involved In Rothmund-Thomson Syndrome
-
批准号:8335886
-
项目类别:
-
资助金额:$38.55万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
An RNA topoisomerase complex interacts with Fragile X syndrome protein to promote neurodevelopment and maintain normal life-span
-
批准号:10003702
-
项目类别:
-
资助金额:$91.4万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
-
批准号:10252555
-
项目类别:
-
资助金额:$30.63万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
Identification and characterization Of A Complex Involved In Bloom Syndrome
-
批准号:10252553
-
项目类别:
-
资助金额:$9.86万
-
财政年份:--
-
负责人:Weidong Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: